Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874507 · ClinicalTrials.gov registry record · NA
Physical Therapy Using Virtual Reality/Augmented Reality
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03874507: Completed NA study, sponsored by Stanford University.
NCT03874507 is a NA study that has completed, run by Stanford University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874507, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality (VR) headset, Augmented Reality (AR) Headset) are more effective than the standard of care (i.e., no technology-based distraction) for improving clinical outcomes in patients requiring acute rehabilitation due to deconditioning and surgery. Measures will include include range of motion, gait progression, strength progression, time to first out of bed, time to first step.
Primary Outcome
Aggregate movement will be measured by either sensors in the VR/AR headset or by a physical therapist during the participants session
Interventions
- OTHER Virtual Reality/Augmented Reality Headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2020-04-25 |
| Phase | NA |
What the finished NCT03874507 record still lists
NCT03874507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality/Augmented Reality Headset is the first listed.
NCT03874507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03874507 about?
NCT03874507 is a clinical study titled "Physical Therapy Using Virtual Reality/Augmented Reality". The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality (VR) headset, Augmented Reality (AR) Headset) are more effective than the standard of care (i.e., no technology-based distraction) for improving clinical outcomes in patients requiring acute rehabilitation...
What is the current status of trial NCT03874507?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-07-25. Estimated completion is 2020-04-25.
What interventions are being tested in trial NCT03874507?
The interventions under investigation include: Virtual Reality/Augmented Reality Headset (OTHER).
Who is sponsoring clinical trial NCT03874507?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03874507's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI